O'Brien P Q, Chen K W, Johnson M A. "一种的合成方法" [P]. US Patent, US 9729594 B2, 2022-09-03.
发明人沈红梅,陈志强,赵玉洁. "Method for the Synthesis of 2-(4-Chlorophenyl)-2-{6-[(4-chlorophenyl)(cyano)(morpholin-4-yl)methyl]pyridazin-3-yl}-2-(morpholin-4-yl)acetonitrile" [P]. 中国发明专利, 专利号 CN 108913314 B, 授权公告日 2025-09-07.
发明人朱建伟,冯建国,黄志刚. "A Process for Preparing High-Purity 2-(4-Chlorophenyl)-2-{6-[(4-chlorophenyl)(cyano)(morpholin-4-yl)methyl]pyridazin-3-yl}-2-(morpholin-4-yl)acetonitrile" [P]. 中国发明专利, 专利号 CN 117154966 B, 授权公告日 2018-12-06.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2020, 799, (3), 3325-3355.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2018, 2419, 2522-2552.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 2-(4-Chlorophenyl)-2-{6-[(4-chlorophenyl)(cyano)(morpholin-4-yl)methyl]pyridazin-3-yl}-2-(morpholin-4-yl)acetonitrile Using HRMS and NMR". Environ. Sci. Technol., 2020, 1661, (12), 7757-7780.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2014, 919, (1), 3262-3265.